DIALECTIC CAPITAL MANAGEMENT LP 13D and 13G filings for Achieve Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-18 5:18 pm Purchase |
2023-04-18 | 13G | Achieve Life Sciences, Inc. ACHV |
DIALECTIC CAPITAL MANAGEMENT LP | 3,593,093 19.990% |
44,093 (+1.24%) |
Filing |
| 2023-03-23 4:45 pm Unchanged |
2023-03-21 | 13D | Achieve Life Sciences, Inc. ACHV |
DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% |
0 (Unchanged) |
Filing |
| 2023-03-06 10:43 am Unchanged |
2023-03-01 | 13D | Achieve Life Sciences, Inc. ACHV |
DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% |
0 (Unchanged) |
Filing |
| 2023-01-20 3:02 pm Unchanged |
2023-01-19 | 13D | Achieve Life Sciences, Inc. ACHV |
DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% |
0 (Unchanged) |
Filing |
| 2022-11-21 4:41 pm Purchase |
2022-11-18 | 13G | Achieve Life Sciences, Inc. ACHV |
DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% |
3,549,000 (New Position) |
Filing |